2. Cardiovascular Disease

Cardiovascular Disease

Cardiovascular Disease

Related Products

PDF 32.36 MB

Cardiovascular diseases (CVDs) are the leading causes of death and disability worldwide. CVDs include diseases of the heart, vascular diseases of the brain and diseases of blood vessels. Caused by atherosclerosis, coronary heart disease and cerebrovascular disease are the most common forms of CVDs. Other less common forms of CVDs include rheumatic heart disease and congenital heart disease. A large percentage of CVDs is preventable through the reduction of behavioral risk factors such as tobacco use, physical inactivity and unhealthy diet. Dietary sodium reduction can alleviate the long-term risk of cardiovascular disease events. Statin therapy is an effective intervention in both the primary and secondary preventions of CVDs in those who are at high risk.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P1815
    C-Type Natriuretic Peptide (1-53), human 141294-77-1 98%
    C-Type Natriuretic Peptide (1-53), human is the 1-53 fragment of C-Type Natriuretic Peptide. C-Type Natriuretic Peptide is natriuretic peptide family peptide that is involved in the maintenance of electrolyte-fluid balance and vascular tone.
    C-Type Natriuretic Peptide (1-53), human
  • HY-P1824
    C-Reactive Protein (CRP) (201-206) 130348-99-1 98%
    C-Reactive Protein (CRP) 201-206 is the 201-206 fragment of C-Reactive Protein. C-Reactive Protein (CRP), the prototypic marker of inflammation, is a cardiovascular risk marker and may promote atherogenesis.
    C-Reactive Protein (CRP) (201-206)
  • HY-P1829
    Angiotensin I/II (1-6) 47896-63-9 98%
    Angiotensin I/II 1-6 contains the amino acids 1-6 and is converted from Angiotensin I/II peptide. The precursor angiotensinogen is cleaved by renin to form angiotensin I. Angiotensin I ishydrolyzed by angiotensin-converting enzyme (ACE) to form the biologically active angiotensin II. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy.
    Angiotensin I/II (1-6)
  • HY-P1836
    C-Reactive Protein (CRP) (77-82) 130349-01-8 98%
    C-Reactive Protein (CRP) 77-82 is the 77-82 fragment of C-Reactive Protein. C-Reactive Protein (CRP), the prototypic marker of inflammation, is a cardiovascular risk marker and may promote atherogenesis.
    C-Reactive Protein (CRP) (77-82)
  • HY-P1838
    Proadrenomedullin (45-92), human 166798-69-2 98%
    Proadrenomedullin (45-92), human, a mid-regional fragment of proadrenomedullin (MR-proADM), comprises amino acids 45–92 of pre-proADM. Proadrenomedullin (45-92), human has a longer half-life, is relatively stable and is produced in equimolar amounts to adrenomedullin (ADM), making it a surrogate for plasma levels of ADM gene products.
    Proadrenomedullin (45-92), human
  • HY-P1839
    Angiotensin I/II (1-5) 58442-64-1 98%
    Angiotensin I/II 1-5 is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy.
    Angiotensin I/II (1-5)
  • HY-P1849
    JAG-1, scrambled 402941-23-5 98%
    JAG-1, scrambled (scJag-1) is a scrambled sequence of JAG-1 (Jagged-1 protein). JAG-1, scrambled has a random sequence of the amino acids that are the same as the active fragment. JAG-1, scrambled is usually used as a negative control.
    JAG-1, scrambled
  • HY-P1858
    Urocortin III, mouse 357952-10-4 98%
    Urocortin III, mouse is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III preferentially binds and activates CRF-R2. Urocortin III (Ucn3) is a known component of the behavioral stress response system. Urocortin III and CRF-R2 in the medial amygdala regulate complex social dynamics.
    Urocortin III, mouse
  • HY-P1908
    sgp91 ds-tat Peptide 2, scrambled 98%
    sgp91 ds-tat Peptide 2, scrambled is a scrambled sequence of NADPH oxidase inhibitor gp91 ds-tat peptide.
    sgp91 ds-tat Peptide 2, scrambled
  • HY-P1913
    Calcitonin Gene Related Peptide (CGRP) II, rat 99889-63-1 98%
    Calcitonin Gene Related Peptide (CGRP) II, rat, a CGRP receptor activator, is a potent and long-lasting vasodilator. Calcitonin Gene Related Peptide (CGRP) II can be used in the research of cardiovascular diseases.
    Calcitonin Gene Related Peptide (CGRP) II, rat
  • HY-P1949
    Cyclic MKEY 98%
    Cyclic MKEY is a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, which protects against atherosclerosis and aortic aneurysm formation by mediating inflammation. Cyclic MKEY also protects against stroke-induced brain injury in mice.
    Cyclic MKEY
  • HY-P2018
    FK 33-824 64854-64-4 98%
    FK 33-824, a synthetic analogue of Met-enkephalin, is a selective agonist of the μ-opioid receptor (μ-OR).
    FK 33-824
  • HY-P2021
    BMS 180742 138828-04-3 98%
    BMS 180742 is a thrombin exosite inhibitor. BMS 180742 does not inhibit arterial thrombosis.
    BMS 180742
  • HY-P2024
    CP-85339 119625-53-5 98%
    CP-85339 is a tetrapeptide renin inhibitor.
    CP-85339
  • HY-P2039
    Retrobradykinin 5991-13-9 98%
    Retrobradykinin has the reverse sequence of Bradykinin (HY-P0206). Retrobradykinin exhibits no kinin activity and can be used as a negative control for Bradykinin.
    Retrobradykinin
  • HY-P2057
    PD 142893 143037-36-9 98%
    PD 142893 is a endothelin-B receptor antagonist.
    PD 142893
  • HY-P2060
    CGP 44099 128856-81-5 98%
    CGP 44099 is a renin inhibitor. CGP 44099 can be used to study the ischemic injury and reperfusion arrhythmias in rat hearts.
    CGP 44099
  • HY-P2061
    Leualacin 128140-12-5 98%
    Leualacin, a calcium channel blocker, can be isolated from the fungus Hapsidospora irregularis.
    Leualacin
  • HY-P2090
    Angiopeptin 113294-82-9 98%
    Angiopeptin, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26 nM and 6.92 nM, respectively. Angiopeptin is a potent inhibitor of growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin has the potential for coronary atherosclerosis research.
    Angiopeptin
  • HY-P2097
    L-363564 86153-46-0 98%
    L-363564 is a renin inhibitor. L-363564 can be used in cardiovascular disease related research.
    L-363564
Cat. No. Product Name / Synonyms Application Reactivity